367 related articles for article (PubMed ID: 19033598)
1. A family of models of angiogenesis and anti-angiogenesis anti-cancer therapy.
D'Onofrio A; Gandolfi A
Math Med Biol; 2009 Mar; 26(1):63-95. PubMed ID: 19033598
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy of vascularised tumours: role of vessel density and the effect of vascular "pruning".
d'Onofrio A; Gandolfi A
J Theor Biol; 2010 May; 264(2):253-65. PubMed ID: 20100496
[TBL] [Abstract][Full Text] [Related]
3. Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999).
d'Onofrio A; Gandolfi A
Math Biosci; 2004 Oct; 191(2):159-84. PubMed ID: 15363652
[TBL] [Abstract][Full Text] [Related]
4. Realizable protocols for optimal administration of drugs in mathematical models for anti-angiogenic treatment.
Ledzewicz U; Marriott J; Maurer H; Schättler H
Math Med Biol; 2010 Jun; 27(2):157-79. PubMed ID: 20513667
[TBL] [Abstract][Full Text] [Related]
5. Modelling approaches for angiogenesis.
Taraboletti G; Giavazzi R
Eur J Cancer; 2004 Apr; 40(6):881-9. PubMed ID: 15120043
[TBL] [Abstract][Full Text] [Related]
6. Mathematical modelling of flow through vascular networks: implications for tumour-induced angiogenesis and chemotherapy strategies.
McDougall SR; Anderson AR; Chaplain MA; Sherratt JA
Bull Math Biol; 2002 Jul; 64(4):673-702. PubMed ID: 12216417
[TBL] [Abstract][Full Text] [Related]
7. Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis.
Ledzewicz U; Schättler H
J Theor Biol; 2008 May; 252(2):295-312. PubMed ID: 18371982
[TBL] [Abstract][Full Text] [Related]
8. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
Wong ML; Prawira A; Kaye AH; Hovens CM
J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
[TBL] [Abstract][Full Text] [Related]
9. Dynamical model for assessment of anti-angiogenic therapy of cancer.
Mukherjee A; Majumder D
Mol Biosyst; 2010 Jun; 6(6):1047-55. PubMed ID: 20358121
[TBL] [Abstract][Full Text] [Related]
10. Anti-Dll4 therapy: can we block tumour growth by increasing angiogenesis?
Sainson RC; Harris AL
Trends Mol Med; 2007 Sep; 13(9):389-95. PubMed ID: 17822956
[TBL] [Abstract][Full Text] [Related]
11. Robustness of optimal controls for a class of mathematical models for tumor anti-angiogenesis.
Schättler H; Ledzewicz U; Cardwell B
Math Biosci Eng; 2011 Apr; 8(2):355-69. PubMed ID: 21631134
[TBL] [Abstract][Full Text] [Related]
12. Microtubule-targeting agents in angiogenesis: where do we stand?
Pasquier E; Honoré S; Braguer D
Drug Resist Updat; 2006; 9(1-2):74-86. PubMed ID: 16714139
[TBL] [Abstract][Full Text] [Related]
13. [Tumour angiogenesis and therapy directed at the neovasculature].
Eikesdal HP; Dahl O; Straume O; Akslen LA
Tidsskr Nor Laegeforen; 2004 Aug; 124(15):1919-22. PubMed ID: 15306859
[TBL] [Abstract][Full Text] [Related]
14. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
Shojaei F; Ferrara N
Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
[TBL] [Abstract][Full Text] [Related]
15. [Dormant tumors and organs resistant to metastasis after gene transfer: dream and reality of anti-angiogenic gene therapy].
Li H; Dkhissi F; Grenet C; Soria C; Lu H
Therapie; 2001; 56(5):501-10. PubMed ID: 11806286
[TBL] [Abstract][Full Text] [Related]
16. [Rationale of antiangiogenic therapy].
Tímár J; Paku S; Tóvári J; Döme B
Magy Onkol; 2006; 50(2):141-51. PubMed ID: 16888678
[TBL] [Abstract][Full Text] [Related]
17. Lattice and non-lattice models of tumour angiogenesis.
Plank MJ; Sleeman BD
Bull Math Biol; 2004 Nov; 66(6):1785-819. PubMed ID: 15522355
[TBL] [Abstract][Full Text] [Related]
18. Tumour angiogenesis.
Arnold F
Ann R Coll Surg Engl; 1985 Sep; 67(5):295-8. PubMed ID: 2413796
[TBL] [Abstract][Full Text] [Related]
19. Model of tumour angiogenesis -- analysis of stability with respect to delays.
Bodnar M; Piotrowska MJ; Foryś U; Nizińska E
Math Biosci Eng; 2013 Feb; 10(1):19-35. PubMed ID: 23311360
[TBL] [Abstract][Full Text] [Related]
20. Selective targeting of the tumour vasculature.
Chan LS; Daruwalla J; Christophi C
ANZ J Surg; 2008 Nov; 78(11):955-67. PubMed ID: 18959693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
